HCA Healthcare Falls 7.8% Post Q1 Beat

HCA Healthcare reported Q1 adjusted EPS of $7.15, marginally beating consensus of $7.14, with revenue $19.11 bn, up 4.3% YoY.
Despite the beat, shares fell 7.81% in pre‑market trading as volume trends weakened and seasonal volume gains were absent.
Respiratory admissions dropped 42% and ER visits 32% YoY, while same‑facility admissions rose only 0.9% and revenue per admission increased 3.1%.
Net income rose 0.6% to $1.62 bn, adjusted EBITDA 1.9% to $3.80 bn, cash flow up 22% to $2.01 bn, and full‑year 2026 guidance reaffirmed.